0001209191-14-060584.txt : 20141001 0001209191-14-060584.hdr.sgml : 20141001 20141001171148 ACCESSION NUMBER: 0001209191-14-060584 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141001 DATE AS OF CHANGE: 20141001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141133858 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-09-30 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & CFO Common Stock 2014-09-30 4 M 0 2267 33.28 A 47537 D Common Stock 2014-09-30 4 M 0 13594 39.05 A 61131 D Common Stock 2014-09-30 4 M 0 11329 33.82 A 72460 D Common Stock 2014-09-30 4 M 0 16993 38.80 A 89453 D Common Stock 2014-09-30 4 M 0 11330 51.75 A 100783 D Common Stock 2014-09-30 4 M 0 16993 37.86 A 117776 D Common Stock 2014-09-30 4 M 0 18126 48.74 A 135902 D Common Stock 2014-09-30 4 M 0 16992 45.11 A 152894 D Common Stock 2014-09-30 4 S 0 14007 111.31 D 138887 D Common Stock 2014-09-30 4 S 0 43112 112.21 D 95775 D Common Stock 2014-09-30 4 S 0 28751 113.10 D 67024 D Common Stock 2014-09-30 4 S 0 22156 113.90 D 44868 D Common Stock 5306 I 401(k) Stock Option (right to buy) 33.28 2014-09-30 4 M 0 2267 0.00 D 2019-07-15 Common Stock 2267 0 D Stock Option (right to buy) 39.05 2014-09-30 4 M 0 13594 0.00 D 2020-02-03 Common Stock 13594 0 D Stock Option (right to buy) 33.82 2014-09-30 4 M 0 11329 0.00 D 2020-07-13 Common Stock 11329 0 D Stock Option (right to buy) 38.80 2014-09-30 4 M 0 16993 0.00 D 2021-02-02 Common Stock 16993 10195 D Stock Option (right to buy) 51.75 2014-09-30 4 M 0 11330 0.00 D 2021-07-12 Common Stock 11330 9062 D Stock Option (right to buy) 37.86 2014-09-30 4 M 0 16993 0.00 D 2022-02-01 Common Stock 16993 23789 D Stock Option (right to buy) 48.74 2014-09-30 4 M 0 18126 0.00 D 2022-07-24 Common Stock 18126 18124 D Stock Option (right to buy) 45.11 2014-09-30 4 M 0 16992 0.00 D 2023-02-04 Common Stock 16992 37383 D Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $111.31 (range $110.61 to $111.60). Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60). Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.59). Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.61 to $114.34). The option vests in 16 quarterly installments from 07/16/2009. The option vests in 16 quarterly installments from 02/04/2010. The option vests in 16 quarterly installments from 07/14/2010. The option vests in 16 quarterly installments from 02/03/2011. The option vests in 16 quarterly installments from 07/13/2011. The option vests in 16 quarterly installments from 02/02/2012. The option vests in 16 quarterly installments from 07/25/2012. The option vests in 16 quarterly installments from 02/05/2013. Kenneth L. Horton, Attorney-In-Fact 2014-10-01